Reproductive medicine and the production of bioartificial organs

Reproductive medicine and the production of bioartificial organs may be a source of hope in the next few years for patients with degenerative lesions of various organs, among them the reproductive organs. Undoubtedly, in this respect, major advances in stem cell knowledge,...
Posted On 12 May 2017
, By

CRISPR used in viable human embryos and germline genetic modification. An ethical approach

From an ethical point of view, the use and destruction of human embryos, members of our species and worthy of full dignity is completely unacceptable and, it should be noted,  these experiments involve genetic modification of the germline, the safety of which is still far from...